Eli Lilly and Company · 21 hours ago
Associate Vice President Global Communications Oncology & Business Development
Eli Lilly and Company is a global healthcare leader headquartered in Indianapolis, Indiana. The Associate Vice President of Therapeutic Area Communications leads global communications strategies for a therapeutic area and oversees business development communications, ensuring alignment with overall business strategy.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Owns global external and internal communications for a therapeutic area, setting strategy and driving execution across U.S. and International markets
Set the global communications execution plan for the therapeutic area and drive execution excellence across markets (U.S. and IBU)
Provide governance and oversight with colleagues in affiliates and global functions to ensure alignment, measurement, and excellence of execution
Lead environment-shaping communications to support strong launches of new molecules and indications integrated with the relevant Global Customer Offer key capabilities
Provide communications support around key data and regulatory milestones, including scientific disclosures and approvals
Develop and implement innovative, consumer-centric approaches that resonate with patients, healthcare providers, and other stakeholders
Establish and maintain relationships with top-tier and emerging media; engage non-traditional outlets (digital creators, podcasters, niche media) to effectively reach target audiences
Lead executive visibility and communications for the Therapeutic Area Business Leader; provide media training, counsel, and coaching to internal partners
Media training, communications counsel and coaching to internal business partners
Manage day-to-day work with PR agencies and other external partners to deliver high-quality outcomes
Anticipate, prioritize, and prepare to manage potential issues in the media; lead agile issues/crisis response
Serve as spokesperson as appropriate; conduct and/or facilitate interviews with local, national, and international media
Establish and lead formal governance structure for BD communications, elevating from current execution-level management to strategic enterprise function
Create and implement standardized processes for how BD communications are managed from deal inception through announcement and integration
Serve as primary communications liaison with Corporate Business Development, Investor Relations, and business unit BD leads to ensure early visibility into pipeline
Build and deploy agile communications teams for BD opportunities, pulling together appropriate expertise (legal, regulatory, medical, investor relations, media relations, employee communications) based on deal scope and complexity
Provide strategic counsel on communications implications of potential deals, including reputation considerations, stakeholder impact, and external positioning
Connect BD activities to overall business and communications strategy, ensuring BD communications planning aligns with therapeutic area priorities, enterprise narrative, and investor positioning
Develop playbooks and frameworks for different types of BD announcements (acquisitions, licensing, partnerships, collaborations, divestitures)
Drive stakeholder mapping and planning for complex BD transactions, ensuring comprehensive internal and external communications plans
Lead an agile team of communications colleagues and coordinate cross-functional readiness spanning early development through commercialization
Qualification
Required
Bachelor's degree in Communications, Public Relations, Journalism, Healthcare, Science, or Policy
Minimum 10 years of experience in Corporate Affairs/Communications or closely related fields (e.g., Government Affairs, Advocacy & Professional Relations, Policy)
Experience in pharmaceutical, biotech, or broader healthcare sectors
Experience managing complex, confidential business transactions and announcements
Qualified applicants must be authorized to work in the United States on a full-time basis. Lilly will not provide support for or sponsor work authorization and/or visas for this role
Demonstrated ability to develop and execute strategic and creative communications plans, including digital and social media
Proven experience setting global communications strategies and driving execution across multiple markets (U.S. and IBU)
Executive presence with the ability to remain calm and effective under pressure; strong interpersonal skills across organizational levels
Track record of collaboration, consensus-building, and influencing cross-functional partners
Project management excellence and learning agility; ability to handle multiple priorities and senior stakeholder interactions
Media relations expertise, including engaging A-list media and serving as a spokesperson
PR agency management and vendor oversight
Experience in executive communications/speechwriting and integrated media strategies (traditional and innovative platforms)
Issues/crisis management capabilities
Experience building processes, frameworks, and governance structures from the ground up
Outstanding written, verbal, and interpersonal communication skills; ability to translate business needs into communications that advance objectives
Preferred
Experience engaging online patient communities in collaboration with affiliate partners
Direct experience supporting scientific data disclosures, regulatory milestones, and launch preparations
Prior experience in M&A communications, business development communications, or investor relations
Experience working directly with Corporate Development or Business Development functions
Financial acumen and understanding of how business transactions impact company valuation and investor perception
Benefits
Company bonus
401(k)
Pension
Vacation benefits
Medical, dental, vision and prescription drug benefits
Flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts)
Life insurance and death benefits
Certain time off and leave of absence benefits
Well-being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities)
Company
Eli Lilly and Company
We're a medicine company turning science into healing to make life better for people around the world.
Funding
Current Stage
Public CompanyTotal Funding
$6.5M2024-02-12Post Ipo Debt· $6.5M
1978-01-13IPO
Leadership Team
Recent News
Company data provided by crunchbase